Skip to main content

coagulation factor XII

The F12 gene provides instructions for making a protein called coagulation factor XII. Coagulation factors are a group of related proteins that are essential for normal blood clotting (coagulation). After an injury, clots protect the body by sealing off damaged blood vessels and preventing further blood loss. Factor XII circulates in the bloodstream in an inactive form until it is activated, usually by coming in contact with damaged blood vessel walls. Upon activation, factor XII interacts with coagulation factor XI. This interaction sets off a chain of additional chemical reactions that form a blood clot.

Video picks for Genes
Video library

Normal function

The F12 gene provides instructions for making a protein called coagulation factor XII. Coagulation factors are a group of related proteins that are essential for normal blood clotting (coagulation). After an injury, clots protect the body by sealing off damaged blood vessels and preventing further blood loss. Factor XII circulates in the bloodstream in an inactive form until it is activated, usually by coming in contact with damaged blood vessel walls. Upon activation, factor XII interacts with coagulation factor XI. This interaction sets off a chain of additional chemical reactions that form a blood clot.

Factor XII also plays a role in stimulating inflammation, a normal body response to infection, irritation, or injury. When factor XII is activated, it also interacts with a protein called plasma kallikrein. This interaction initiates a series of chemical reactions that lead to the release of a protein fragment (peptide) called bradykinin. Bradykinin promotes inflammation by allowing fluids to leak through the blood vessel walls into body tissues (vascular permeability). This leakage causes the swelling that accompanies inflammation.

Conditions referring to this gene or chromosome

Other names

coagulation factor XII (Hageman factor)

FA12_HUMAN

HAE3

HAEX

HAF

Hageman factor

Patient picks for Genes

Related patient information and medicines

Blood clotting tests

Patient information leaflet

Blood clotting tests

Blood clotting tests are used to diagnose and assess bleeding problems and to monitor people who take warfarin or other anticoagulant medicines. You may be advised to have blood clotting tests: If you h... These chemicals then react with other chemicals and proteins in the plasma, called clotting factors. There are 13 known clotting factors which.

Pre-eclampsia

Patient information leaflet

Pre-eclampsia

The National Institute for Health and Care Excellence (NICE) recommends that women at increased risk of developing pre-eclampsia should take low-dose aspirin. NICE recommends 75-150 mg asp... The risk of complications is reduced if pre-eclampsia is diagnosed early and treated. A rare but serious complication is disseminated intravascular.

Thrombophilia

Patient information leaflet

Thrombophilia

The clotting cascade makes the blood solidify into a clot, which sticks to the injured part of the blood vessel. Small particles in the blood, called platelets, also help to form the clot. There are also natural chemicals in the blood which act against the clotting system, to stop the blood clotting too much. Thrombophilia occurs if the normal.

Barrett's oesophagus

Patient information leaflet

Barrett's oesophagus

The coil then emits heat energy which destroys the abnormal cells. Nearby normal cells then multiply and replace the destroyed abnormal cells. Argon plasma coagulation This treatment uses a jet of argon gas, together with an electric current, to burn away dysplastic cells. Endoscopic mucosal resection (EMR) This is a procedure that is done via.

Piles

Patient information leaflet

Piles

Banding treatment (rubber band ligation) Banding is the most commonly used piles treatment, especially for grade 2 and 3 piles. Infrared coagulation/photocoagulation This method of piles treatment uses infrared light to burn and cut off the circulation to the haemorrhoid, which causes it to shrink in size. It may be as effective as banding.

Anticoagulants

Patient information leaflet

Anticoagulants

In 2021, the UK's National Institute for Health and Care Excellence (NICE) recommended that DOACs should be the preferred option for AF, instead of warfarin. These activated platelets and the damaged tissue release chemicals which react with other chemicals and proteins in the blood, called clotting factors. There are 13 known clotting factors.

Further reading and references

Article history

The information on this page is written and peer reviewed by qualified clinicians.
  • 11 Mar 2024 | Latest version
  • 1 Mar 2024 | Originally published

Join the conversation

Share your thoughts or experiences with others in our patient communities.

Disclaimer: The views expressed in the community do not represent medical advice. For any health concerns, consult your GP or healthcare provider.

Online pharmacy, treatments and health services

Simple access to trusted treatments and health services online.

Common conditions

Get help with common conditions through the NHS, without a GP appointment.

Book your free Pharmacy First appointment

Sign up to the Patient newsletter

Your weekly dose of clear, trustworthy health advice - written to help you feel informed, confident and in control.

Please enter a valid email address

By subscribing you accept our Privacy Policy. You can unsubscribe at any time. We never sell your data.